Keywords: novartis, prexige, benefits, oa, patients, findings, key

Novartis' Prexige benefits OA patients

Article | 30 June 2003

Print This

Findings from key Phase III studies, presented for the first time at the European League Against Rheumatism annual congress in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in